Comparing Deflazacort vs Medrol
| Deflazacort | Medrol (methylprednisolone) |
|
|---|
| Deflazacort | Medrol (methylprednisolone) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Duchenne Muscular Dystrophy. Deflazacort may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Asthma, Allergic Rhinitis, Asthma - Maintenance, Asthma - acute, Congenital Adrenal Hyperplasia, Dermatologic Lesion, Gout - Acute, Immunosuppression, Inflammatory Conditions, Multiple... View more |
||||||||
| More about Deflazacort | More about Medrol (methylprednisolone) | ||||||||
| Ratings & Reviews | |||||||||
|
Be the first to share your experience with this drug. |
Medrol has an average rating of 5.2 out of 10 from a total of 12 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Deflazacort side effects |
View all Medrol side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Medrol prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Emflaza, Jaythari | Other methylprednisolone brands include: Depo-Medrol, Medrol Dosepak, MethylPREDNISolone Dose Pack, Solu-Medrol | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
3.5 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 578 drugs are known to interact with Deflazacort:
|
A total of 627 drugs are known to interact with Medrol:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
|
|||||||||
| First Approval Date | |||||||||
|
February 09, 2017 |
October 24, 1957 |
||||||||
| WADA Class View classifications | |||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
|
N/A |
|||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Emflaza
Emflaza (deflazacort) is a corticosteroid medication used to treat a rare genetic disorder called ...
Viltepso
Viltepso (viltolarsen) is used for the treatment of Duchenne muscular dystrophy (DMD) treatable ...
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Golodirsen
Golodirsen is used to treat Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Givinostat
Givinostat (Duvyzat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.